Literature DB >> 21388856

Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression.

Eline Dejonckheere1, Roosmarijn E Vandenbroucke, Claude Libert.   

Abstract

The predominant role of matrix metalloproteinase 8 in extracellular matrix turnover, modulation of inflammatory responses and other physiological processes is well documented. Several recent studies highlight the involvement of MMP8 in a wide range of pathologies. This review will shed light on the putative role of MMP8 as a drug target or disease marker in some inflammatory disorders and in cancer progression.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388856     DOI: 10.1016/j.cytogfr.2011.02.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  36 in total

1.  Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Piya Chaemsaithong; Roberto Romero; Nikolina Docheva; Noppadol Chaiyasit; Gaurav Bhatti; Percy Pacora; Sonia S Hassan; Lami Yeo; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

Review 2.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

3.  Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.

Authors:  Hemant Kumar; Min-Jae Jo; Hyemin Choi; Manjunatha S Muttigi; Seil Shon; Byung-Joo Kim; Soo-Hong Lee; In-Bo Han
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

4.  Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.

Authors:  Jeong Eun Han; Eun-Jung Lee; Eunjung Moon; Jong Hoon Ryu; Ji Woong Choi; Hee-Sun Kim
Journal:  Mol Neurobiol       Date:  2014-11-26       Impact factor: 5.590

Review 5.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

6.  Cytokine and Gene Expression Profiling in Patients with HFE-Associated Hereditary Hemochromatosis according to Genetic Profile.

Authors:  Heidi Kristine Grønlien; Trine Eker Christoffersen; Camilla Furlund Nystrand; Lamya Garabet; Terje Syvertsen; Morten K Moe; Ole Kristoffer Olstad; Christine Monceyron Jonassen
Journal:  Acta Haematol       Date:  2020-12-16       Impact factor: 2.195

Review 7.  Pathophysiology and Genetics of Bronchiectasis Unrelated to Cystic Fibrosis.

Authors:  Aleksandra Nikolic
Journal:  Lung       Date:  2018-05-12       Impact factor: 2.584

8.  Mechanistic investigations of matrix metalloproteinase-8 inhibition by metal abstraction peptide.

Authors:  Jenifer K Tucker; Michaela L McNiff; Sasanka B Ulapane; Paulette Spencer; Jennifer S Laurence; Cindy L Berrie
Journal:  Biointerphases       Date:  2016-06-29       Impact factor: 2.456

9.  Development and Validation of a Small Single-domain Antibody That Effectively Inhibits Matrix Metalloproteinase 8.

Authors:  Delphine Demeestere; Eline Dejonckheere; Sophie Steeland; Paco Hulpiau; Jurgen Haustraete; Nick Devoogdt; Rielana Wichert; Christoph Becker-Pauly; Elien Van Wonterghem; Sylviane Dewaele; Griet Van Imschoot; Jeroen Aerts; Lutgarde Arckens; Yvan Saeys; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mol Ther       Date:  2016-01-18       Impact factor: 11.454

10.  Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis.

Authors:  Shaohui Qiu; Peng He; Xin Fang; Haiqing Tong; Jingjing Lv; Jiaye Liu; Li Zhang; Xiangjun Zhai; Liying Wang; Zhongyu Hu; Yongli Yu
Journal:  Hum Vaccin Immunother       Date:  2018-05-14       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.